EFTA02676113

From: Robin L. Davisson < Sent: Monday, December 21, 2015 8:20 PM To: [email protected] Subject: FW: Thank you from MRA Attachments: Anonymous_Invoice.pdf From: Robin L. Davisson Sent: Saturday, December 19, 2015 5:53 PM To: [email protected] Subject: Thank you from MRA December 19, 2015 = &n=sp; &n=sp; &n=sp; Attn: Jeffrey Epstein [email protected] <mailto:[email protected]> Jeffrey Epstein VI Foundation 6100 Red Hook Quarters, Suite B-3 St. Thomas, Virgin Islands 00802-1348 Dear Mr. Epstein: > We are so grateful for y=ur continued support of our work at the Melanoma Research Alliance (MRA). =e were delighted to receive your commitment to MRA's biennial benefi= dinner at Sotheby's to support MRA's research portfolio. =/p> More than 200 supporters joined us in celebrating th= progress taking place in the field of melanoma research during our benefi= dinner last month. It truly was a wonderful night, as we honored the scie=tists and doctors who are dedicated to defeating this disease, and also raised $5.8 million. As you know, 100%=of all funds raised go directly to support MRA's research program. EFTA_R1_01966918 EFTA02676113 Please allow this letter to serve as confirmation of=your pledge for $225,000 for a Young Investigator Award. The Young Investigator Award program aims to at=ract early career scientists with novel ideas into melanoma research, ther=by recruiting and supporting the next generation of melanoma scientists. &n=sp; Since we began our work, we have seen dramatic progr=ss in the field, with 11 new therapies coming to market for patients with =elanoma — including three in the last month! MRA has been at the for=front of some of the most promising research, providing critical funding to elevate the pace of discovery. The impact is=being felt throughout the field of oncology. Enclosed please find an invoice for your commitment.=Please contact Logan Kastner, Director of Development and Marketing, at or </=> <mailto >, with any questions. At the Melanoma Research Alliance, we are committed =o funding the best research and brightest minds throughout the world. With=your support, we will continue to change the field for all those impacted =y melanoma. With sincere appreciation, Robin L. Davisson, Ph.D. President & CEO-Elect 2 EFTA_R1_01966919 EFTA02676114